Vir Biotechnology (VIR) Other Gross PP&E Adjustments (2018 - 2026)

Vir Biotechnology's Other Gross PP&E Adjustments history runs 9 years deep, the most recent figure standing at $38.9 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments fell 2.54% year-over-year to $38.9 million; the TTM figure through Mar 2026 stood at $38.9 million (down 2.54% YoY), while the FY2025 annual figure was $37.4 million, up 126.22% from the prior year.
• Other Gross PP&E Adjustments came in at $38.9 million for Q1 2026 at Vir Biotechnology, up from $37.4 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $56.8 million in Q1 2024 to a low of -$11.6 million in Q1 2022.
• A 5-year average of $32.0 million and a median of $35.9 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments surged 457.58% in 2023 and slumped 32.12% in 2024, its largest moves.
• Vir Biotechnology's Other Gross PP&E Adjustments stood at $19.5 million in 2022, then grew by 22.06% to $23.9 million in 2023, then tumbled by 30.79% to $16.5 million in 2024, then jumped by 126.22% to $37.4 million in 2025, then gained by 4.16% to $38.9 million in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $38.9 million, $37.4 million, and $35.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison